Funding agencies: This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Science Research and Development Service and University of Wisconsin Institute for Clinical and Translational Research, funded through a National Institutes of Health Clinical and Translational Science Award (grant number 1UL1RR025011). This work was supported with the use of facilities at the William S. Middleton Memorial Veterans Hospital Geriatric Research Education and Clinical Center and the Waisman Laboratory for Brain Imaging and Behavior, Madison, Wisconsin.
Article first published online: 2 JUN 2011
Copyright © 2011 Movement Disorder Society
Volume 26, Issue 11, pages 2032–2038, September 2011
How to Cite
Gallagher, C. L., Christian, B. T., Holden, J. E., Dejesus, O. T., Nickles, R. J., Buyan-Dent, L., Bendlin, B. B., Harding, S. J., Stone, C. K., Mueller, B. and Johnson, S. C. (2011), A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease. Mov. Disord., 26: 2032–2038. doi: 10.1002/mds.23778
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 19 SEP 2011
- Article first published online: 2 JUN 2011
- Manuscript Accepted: 11 APR 2011
- Manuscript Revised: 10 MAR 2011
- Manuscript Received: 6 JAN 2011
This article has been cited by: